Ken Fisher Sold These 5 Stocks Before Entering 2022

4. LivaNova PLC (NASDAQ:LIVN)

Number of Hedge Fund Holders: 32

LivaNova PLC (NASDAQ:LIVN) is a company that manufactures medical equipment for cardiac surgery and neuromodulation. Ken Fisher has been bullish on LivaNova PLC (NASDAQ:LIVN) since Q1 2016, when he purchased 52,000 shares of the company, worth $2.85 million. He sold off his stake in LivaNova PLC (NASDAQ:LIVN) in Q3 2017, before acquiring a position in the company again in Q4 2017. As of Q3 2021, he held an $8.8 million stake in LivaNova PLC (NASDAQ:LIVN), which he discarded entirely in Q4 2021. 

On December 7, Piper Sandler analyst Adam Maeder kept his Overweight rating and a $105 price target on LivaNova PLC (NASDAQ:LIVN). The analyst told investors that LivaNova PLC (NASDAQ:LIVN)’s neuromodulation pipeline continues to track in-line with previous guideposts in terms of its key initiatives, and he called the stock his “favorite idea” heading into 2022.

According to the third quarter database of Insider Monkey, 32 hedge funds held long positions in LivaNova PLC (NASDAQ:LIVN), down from 36 funds in the quarter earlier. Harris Associates held the largest position in LivaNova PLC (NASDAQ:LIVN) in Q3 2021, with 3.8 million shares worth $302 million. 

Here is what Diamond Hill Small Cap Fund has to say about LivaNova PLC (NASDAQ:LIVN) in its Q3 2021 investor letter:

“Our health care holdings were negative in aggregate, but outpaced index peers, which boosted relative performance along with our below-benchmark positioning on an individual holdings’ basis, we exited global medical technology company LivaNova as shares approached our estimate of intrinsic value.”